Keywords: 3b, drug-eluting, stent, market, millennium, research, group

$3B US drug-eluting stent market by 2011

Article | 05 March 2007

Millennium Research Group has conducted a detailed analysis of the interventional cardiology market in its US Markets for Interventional Cardiology ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Abbott

Abbott Laboratories

Go to company listing